Plain-English translation of NCT06005740 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is one of the first times this treatment has been tested in people.
This is a first-in-human study testing a new experimental medication called in patients with advanced cancer. Researchers want to learn whether this medication is safe, how well people tolerate it, and whether it helps shrink tumors. The study will involve about 70 patients and is divided into two parts: an initial dose-finding phase and an expansion phase.
This medication has never been tested in humans before, so doctors need to carefully study how it works, what side effects it causes, and whether it shows promise against advanced cancers. This early-stage research is an important first step toward potentially offering new treatment options for patients with advanced solid tumors.
You would receive the medication by IV infusion once every three weeks. The study has two parts: first, researchers will test different doses to find the safest and most effective dose; then, more patients will receive that chosen dose. You would have regular clinic visits for blood tests, imaging scans, and check-ins to monitor how you are doing and whether the medication is working.
AI-generated summary from trial data · Aug 4, 2026 · Not medical advice
United States